Early reports of myocarditis in young males after mRNA COVID vaccination were labeled misinformation and censored on social media. The CDC later confirmed rates of 62.8 cases per million second doses in males aged 12-17, and 50.5 per million in ages 18-24. The CDC ultimately changed its recommendations, extending the interval between doses to reduce risk. Autopsy studies confirmed vaccine-induced myocardial inflammation.